POLICY IMPACT COMMUNICATIONS, INC.

Lobbying for CHROMADEX · Niagen bioscience focusing on the potential of NAD+.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · posted Feb 12, 2026

Lobbying activity 1

Health Issues

Protecting DSHEA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem